Clever Leaves Holdings shares gain on Q4 revenue beat
** Medical cannabis producer's shares CLVR.O up ~9.5% at
$1.73 after market
** Company says Q4 revenue rose 25% to $4.20 mln vs est
$4.13 mln - Refinitiv data
** CLVR posts Q4 loss of $0.91/shr vs est of a loss of
$0.53/shr
** Company continues to expect full-year 2022 revenue
between $20 mln and $25 mln
** CLVR stocks down 49% YTD
(Reporting by Aishwarya Nair in Bengaluru)
Recent news on Clever Leaves Holdings
See all newsBrief: Clever Leaves Holdings Provided Notice To Canaccord Genuity To Terminate Certain Equity Distribution Agreement
Brief: Clever Leaves Holdings' Unit Northern Swan Deutschland Entered Into First Share Purchase And Transfer Agreement
Brief: Clever Leaves Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Clever Leaves Says Colombian Flower Is Now Available To Australian Patients
Brief: Clever Leaves And Astrasana Partner To Establish International Supply Agreement For Medical Cannabis Extracts In Czech Republic And Switzerland